logo

Clinical Trial Results

Share

pharmaup-feb19.jpg The following are some of today's top gainers in the pharma/biotech sector.

Pfizer Inc. (PFE) and Eli Lilly and Company (LLY) announced positive top-line results from a Phase 3 study evaluating tanezumab in patients with moderate-to-severe chronic low back pain. In the study, treatment with tanezumab 10 mg met the primary endpoint, demonstrating a statistically significant improvement...

pharmaup-feb14.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharma-042617_13feb19.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmaup-feb12.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmaup-feb11.jpg The following are some of today's top gainers in the pharma/biotech sector.

MacroGenics, Inc. (MGNX) announced positive results from SOPHIA, the company's Phase 3 clinical study of margetuximab in HER2-positive metastatic breast cancer patients. MacroGenics anticipates submitting a Biologics License Application (BLA) to the U.S. Food and Drug Administration in the second half...

pharmaup-feb04.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmaup-jan31.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmaup-jan30.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmaup-jan29.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmadown-jan28.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

pharmaup-jan28.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmadown-jan22.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

pharmaup-jan22.jpg The following are some of today's top gainers in the pharma/biotech sector.

Follow RTT